Study validates prediction of drug resistance in rifampicin-resistant tuberculosis
A cross-country validation study examines how to predict fluoroquinolone resistance among patients with rifampicin-resistant tuberculosis. The research concerns treatment selection for a difficult-to-treat form of TB.
By DoomRadar · Published on DoomRadar .
Why it matters
Drug-resistant tuberculosis can complicate treatment and increase the risk of transmission and wider public-health burdens.
Related source links
These links were collected with this event. Recorded source dates may reflect when a link was found. Article publication dates are shown only when available from the source. Open the originals for their full context.
- Predicting resistance to fluoroquinolones among patients with rifampicin-resistant tuberculosis: A cross-country validation study ↗journals.plos.org · Recorded source date: Sep 15, 2026, 9:17 PM UTC
AI-assisted, source-based analysis. Methodology · Report a correction